Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial

Affiliations

• ¹ Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9047, USA.
• ² Parkland Health and Hospital System, 5200 Harry Hines Blvd, Dallas, TX 75235, USA.
• ³ Unit of Cardiology, Department of Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
• ⁴ Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ⁵ Pfizer Inc, Groton, CT, USA.
• ⁶ Division of Nephrology, University Health Network, University of Toronto, Toronto, ON, Canada.
• ⁷ University of Tennessee Health Science Center, Memphis, TN, USA.
• ⁸ AdventHealth Translational Research Institute, Orlando, FL, USA.
• ⁹ Pfizer Inc, New York, NY, USA.
• ¹⁰ Merck & Co., Inc, Rahway, NJ, USA.